Authors:
Stange, EF
Riemann, J
von Herbay, A
Lochs, H
Fleig, WE
Scholmerich, J
Kruis, W
Porschen, R
Bruch, HP
Zeitz, M
Schreiber, S
Moser, G
Matthes, H
Selbmann, HK
Goebell, H
Caspary, WF
Citation: Ef. Stange et al., Diagnosis and therapy of ulcerative colitis - results of an evidence-basedConsensus conference of the German Society of Gastroenterology and Metabolic Diseases, Z GASTROENT, 39(1), 2001, pp. 19
Authors:
Halm, U
Schiefke, I
Fleig, WE
Mossner, J
Keim, V
Citation: U. Halm et al., Ofloxacin and ursodeoxycholic acid versus ursodeoxycholic acid alone to prevent occlusion of biliary stents: A prospective, randomized trial, ENDOSCOPY, 33(6), 2001, pp. 491-494
Authors:
Wagner, AD
Feist, T
Prondzinsky, R
Fleig, WE
Keysser, G
Citation: Ad. Wagner et al., Joint and muscle pain with mononeuritis multiplex, tetraparesis, and myocardial infarction in a previously healthy adult, ANN RHEUM D, 60(11), 2001, pp. 1003-1006
Authors:
Lochs, H
Mayer, M
Fleig, WE
Mortensen, PB
Bauer, P
Genser, D
Petritsch, W
Raithel, M
Hoffmann, R
Gross, V
Plauth, M
Staun, M
Nesje, LB
Citation: H. Lochs et al., Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's disease Study VI, GASTROENTY, 118(2), 2000, pp. 264-273
Authors:
Runge, D
Kohler, C
Kostrubsky, VE
Jager, D
Lehmann, T
Runge, DM
May, U
Stolz, DB
Strom, SC
Fleig, WE
Michalopoulos, GK
Citation: D. Runge et al., Induction of cytochrome P450 (CYP)1A1, CYP1A2, and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance (MDR-1) and multidrug resistance associated protein (MRP-1) by prototypical inducers in human hepatocytes, BIOC BIOP R, 273(1), 2000, pp. 333-341
Authors:
Runge, D
Runge, DM
Jager, D
Lubecki, KA
Stolz, DB
Karathanasis, S
Kietzmann, T
Strom, SC
Jungermann, K
Fleig, WE
Michalopoulos, GK
Citation: D. Runge et al., Serum-free, long-term cultures of human hepatocytes: Maintenance of cell morphology, transcription factors, and liver-specific functions, BIOC BIOP R, 269(1), 2000, pp. 46-53
Citation: E. Lotterer et al., Transjugular intrahepatic portosystemic shunt: Short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis, HEPATOLOGY, 29(3), 1999, pp. 632-639
Citation: We. Fleig et G. Kleber, Hepatic artery flow change and hepatocyte oxygenation in human cirrhosis -Reply, GASTROENTY, 117(5), 1999, pp. 1258-1259
Authors:
Kleber, G
Steudel, N
Behrmann, C
Zipprich, A
Hubner, G
Lotterer, E
Fleig, WE
Citation: G. Kleber et al., Hepatic arterial flow volume and reserve in patients with cirrhosis: Use of intra-arterial Doppler and adenosine infusion, GASTROENTY, 116(4), 1999, pp. 906-914